Mainstream

Castle Biosciences raises 2025 revenue guidance to $310M–$320M following strong Q2 execution and test volume growth

Castle Biosciences raises 2025 revenue guidance to $310M–$320M following strong Q2 execution and test volume growth

Post ContentcstlRead More

You might also be interested in reading Draper Goren Holm adds Tezos startups to its $25M venture fund.

August 5, 2025
In Mainstream